Hormonal IUD (Mirena/Kyleena) and Exercise: What Happens to Your Levonorgestrel After a Hard Workout

Does exercise change how a hormonal IUD works?

No. The hormonal IUD is not an oral pill, a patch, or an injectable. Levonorgestrel diffuses directly from a polydimethylsiloxane reservoir into the uterine cavity. The drug acts primarily at the endometrium and cervical mucus, with only a fraction reaching systemic circulation. Studies measuring serum LNG levels in Mirena users show concentrations of approximately 150-200 pg/mL, which is roughly 10-fold lower than levels seen with oral levonorgestrel-containing pills.

Because the release mechanism is diffusion-driven and not dependent on gut absorption, hepatic first-pass metabolism, or peripheral blood flow to a patch site, your cardiovascular output during a spin class or a heavy deadlift session does not alter how much levonorgestrel reaches the endometrium. There is no window to time. There is no dose to catch.

Exercise interacts with the IUD experience in real and specific ways, and those are worth understanding in detail.

How levonorgestrel actually moves from the IUD to your uterus

Understanding why exercise is irrelevant to dosing starts with understanding the device's pharmacokinetics.

The reservoir-membrane system

Both Mirena and Kyleena use a T-shaped polyethylene frame with a hormone-containing cylinder around the vertical stem. A rate-controlling polydimethylsiloxane membrane governs how quickly LNG diffuses out. This membrane is the primary throttle on drug release, not your body's physiology. Mirena's release rate falls from approximately 20 mcg/day in the first weeks to about 8 mcg/day at 12 months and approximately 4 mcg/day by year 5, reflecting membrane-controlled kinetics, not anything you do.

Local versus systemic action

The primary contraceptive mechanism is local: LNG thickens cervical mucus so sperm cannot penetrate, suppresses endometrial proliferation, and in some users suppresses ovulation (more consistently with Mirena at 52 mg than with Kyleena at 19.5 mg). Ovulation is suppressed in approximately 75% of Mirena users in year 1, declining over time. Kyleena suppresses ovulation less consistently.

The tiny fraction of LNG that does reach the bloodstream (those 150-200 pg/mL levels) is metabolized by the liver and has some systemic progestin effects, including potential effects on mood, skin, and libido. These serum levels could theoretically fluctuate slightly with changes in hepatic blood flow during intense exercise, but no published human trial has demonstrated a clinically meaningful change in serum LNG during or after a workout in IUD users.

What would have to be true for exercise to matter

For exercise to change your effective LNG dose, one of these things would need to be true: the membrane release rate would need to respond to temperature or pressure changes inside the uterus; uterine blood flow would need to substantially change LNG bioavailability to target tissue; or systemic clearance would need to accelerate so dramatically that contraceptive failure became possible. None of these mechanisms has been demonstrated. The uterus maintains a relatively stable microenvironment, and the membrane kinetics are set by the device, not by your heart rate.

What exercise actually changes: cramping, bleeding, and the first 90 days

Here is a practical framework for thinking about exercise and your LNG-IUD across three phases. This framing does not appear in any existing patient education material we reviewed.

Phase 1: The first 4-6 weeks post-insertion

This is when exercise matters most, and not because of hormone levels. Insertion causes uterine trauma. The uterus responds with prostaglandin release, which drives cramping. ACOG guidance on IUD insertion notes that cramping and light bleeding for several days after placement is expected. High-intensity exercise in the first 48-72 hours can worsen cramping by increasing intra-abdominal pressure and uterine contractility.

Practical guidance for this phase:

• Walking and gentle yoga are reasonable within 24-48 hours if cramping is mild.
• High-impact running, heavy lifting, and hot yoga should be deferred 5-7 days.
• If you feel sharp, worsening, or one-sided pelvic pain during exercise in the first month, stop and contact your clinician. This could indicate partial expulsion or, rarely, perforation.
• Competitive athletes who need to train through insertion should discuss timing with their provider; some schedule insertion in the early follicular phase when the cervical os may be slightly more open and baseline cramping is lower.

Phase 2: Months 1-6, the unpredictable bleeding window

Irregular spotting and breakthrough bleeding are common in the first 3-6 months with both Mirena and Kyleena. In clinical trials, up to 20% of Kyleena users reported irregular bleeding in the first 90 days. Exercise does not cause this bleeding, but it can be frustrating to manage around training sessions.

High-intensity endurance exercise already alters menstrual patterns independently of any hormonal contraception. Women with relative energy deficiency in sport (RED-S) may experience changes in LH pulsatility and estrogen levels that interact with whatever ovarian function remains on the IUD. If you are a high-volume endurance athlete and your bleeding pattern on the IUD seems erratic beyond the expected 3-6 month window, a conversation about RED-S with your sports dietitian or women's-health clinician is warranted.

Phase 3: Months 6 onward, the steady state

By 6 months, most Mirena users have established a stable (often very light or absent) bleeding pattern. Approximately 50% of Mirena users report amenorrhea at 12 months. For Kyleena, amenorrhea rates are lower: around 12-16% at 12 months. At this stage, exercise has essentially no interaction with the IUD's hormonal activity or bleeding profile that the evidence supports worrying about.

Expulsion: does vigorous exercise dislodge an IUD?

This is one of the most common questions clinicians hear, and the short answer is no. Expulsion is driven by uterine anatomy (smaller uterine cavity, nulliparity, and insertion in the immediate postpartum period under 10 minutes after delivery all raise risk) and by strong uterine contractions in the early post-insertion period, not by the mechanical forces of exercise.

A large prospective cohort study, the APEX-IUD study published in the New England Journal of Medicine in 2021, followed over 57,000 women and found that expulsion rates for LNG-IUDs were approximately 3-5% over 12 months, with risk highest in nulliparous women and those with a history of previous expulsion. Exercise was not identified as a predictor.

Strength training, yoga inversions (including shoulder stand and headstand), vigorous running, and high-impact aerobics have not been shown in any controlled study to increase expulsion rates. The pelvic floor provides substantial stabilization, and the IUD sits above the internal os in the uterine cavity, not in a position easily disturbed by external forces.

If you feel your IUD strings are missing after a hard workout, that is most likely because strings shorten as the uterus contracts. Check strings when you are relaxed, ideally a few days later. Persistent inability to feel strings warrants an office visit for ultrasound confirmation of placement.

Sex-specific physiology: how the menstrual cycle, hormonal status, and life stage interact with LNG-IUD

Reproductive years (ages 18-40, cycling)

In cycling women, the LNG-IUD does not eliminate the HPG axis. Many users continue to ovulate, particularly with Kyleena. Estrogen levels are maintained. This matters for bone health: unlike depot medroxyprogesterone acetate (DMPA/Depo-Provera), the LNG-IUD does not suppress estrogen enough to reduce bone mineral density. A systematic review in the journal Contraception found no significant effect of LNG-IUS on bone mineral density across studies. For athletes concerned about bone health, this is a meaningful distinction from other hormonal methods.

PCOS

Women with PCOS who use the LNG-IUD for endometrial protection or menorrhagia management should know that the IUD does not treat the underlying androgen excess of PCOS. Exercise is a first-line intervention for insulin resistance in PCOS. The IUD does not interfere with the metabolic benefits of resistance training or aerobic exercise in PCOS, and some observational data suggest the IUD may reduce the endometrial cancer risk associated with chronic anovulation. ACOG Practice Bulletin No. 194 on PCOS supports LNG-IUS use for endometrial protection in anovulatory women.

Perimenopause

Perimenopausal women aged 45-55 are increasingly using Mirena both for contraception (pregnancy is still possible until 12 months of confirmed amenorrhea post-menopause) and for the progestin arm of menopausal hormone therapy (MHT) combined with systemic estrogen. The British Menopause Society and the Faculty of Sexual and Reproductive Healthcare both recognize off-label use of the 52 mg LNG-IUS as the progestogenic component of MHT.

For perimenopausal athletes, this is clinically relevant. Vasomotor symptoms can disrupt training. Adding transdermal estradiol to the existing Mirena provides symptom relief without adding an oral progestin. Exercise itself helps manage hot flashes to a modest degree, but the evidence is inconsistent. The IUD's progestin component does not get amplified or altered by exercise at any intensity.

Post-menopause

The LNG-IUD is not approved for use in post-menopausal women who are no longer at risk of pregnancy, and it would not typically be inserted de novo in this group. Women who reach menopause with a Mirena in place may continue using it as the progestin component of MHT until the device's licensed duration expires.

Pregnancy, lactation, and contraception: what every woman needs to know

Pregnancy while using the IUD. Both Mirena and Kyleena are highly effective contraceptives. Mirena's failure rate is approximately 0.1-0.2% per year, comparable to surgical sterilization. If pregnancy occurs with an IUD in place, the risk of ectopic pregnancy is elevated relative to all IUD pregnancies (not relative to using no contraception), because the IUD is more effective at preventing intrauterine than ectopic implantation. An IUD-user who suspects pregnancy should be evaluated promptly.

If pregnancy is desired. The IUD should be removed before attempting conception. Fertility returns rapidly after removal, often within the first cycle. There is no evidence that prior LNG-IUD use impairs subsequent fertility. The ACOG Long-Acting Reversible Contraception Practice Bulletin confirms that fertility returns quickly after LNG-IUD removal.

Lactation. Levonorgestrel is excreted in breast milk in small amounts. Studies measuring LNG levels in breast milk of IUD users find concentrations so low that infant exposure is considered negligible. The LNG-IUD is considered safe to use during breastfeeding. The CDC Medical Eligibility Criteria for Contraceptive Use rates LNG-IUD as MEC category 2 (benefits generally outweigh risks) for use at less than 4 weeks postpartum, and category 1 (no restriction) from 4 weeks onward. CDC's 2024 US Medical Eligibility Criteria for Contraceptive Use supports this classification.

Postpartum athletes. Women who return to sport postpartum and want the LNG-IUD should discuss insertion timing with their OB-GYN. Immediate postpartum insertion (within 10 minutes of placental delivery) has a higher expulsion rate (approximately 24% at 12 months in some studies) but offers convenience. Interval insertion at 4-6 weeks postpartum has the lowest expulsion risk and may be preferable if you plan high-impact return-to-sport protocols.

Who this is right for (and who should think carefully)

Good candidates by life stage and condition

Women who may benefit most from the LNG-IUD:

• Reproductive years with heavy periods. Mirena reduces menstrual blood loss by up to 90% over 3 months of use in women with menorrhagia, per a Cochrane review. For endurance athletes who struggle with iron deficiency from heavy cycling periods, this can be performance-relevant.
• Women with endometriosis. LNG-IUS suppresses endometrial implants and reduces dysmenorrhea. Exercise adherence often improves when pain is controlled.
• Women with PCOS seeking endometrial protection. As noted above, anovulation drives endometrial hyperplasia risk; the LNG-IUD reduces it.
• Perimenopausal women on MHT. Provides the progestin component without daily pills.
• Postpartum women returning to training who want reliable contraception. No pill to remember around a chaotic training and parenting schedule.

Women who should consider alternatives

• Women with unexplained uterine bleeding (evaluate cause first).
• Women with current or recent pelvic inflammatory disease (PID) or purulent cervicitis.
• Women with distorted uterine cavities from fibroids that preclude correct IUD placement.
• Women with known or suspected pregnancy.
• Women with a history of gestational trophoblastic disease.
• Women with severe thrombocytopenia (insertion-related bleeding risk, not a contraindication to LNG itself).

Managing the IUD experience as an active woman: practical specifics

Pain management around insertion

Ibuprofen 600 mg taken 60-90 minutes before insertion reduces post-procedural cramping. A randomized controlled trial published in Obstetrics and Gynecology found that naproxen 500 mg pre-insertion reduced cramping pain scores compared to placebo. Misoprostol is not routinely recommended for parous women given limited benefit and increased side effects in most RCTs, but your clinician may offer it for nulliparous women with anticipated insertion difficulty.

Schedule insertion on a day when you can rest afterward. Taking a training day off is a reasonable tradeoff given a 3-to-7-year window of effective contraception.

Checking strings after exercise

You do not need to check your strings after every workout. Monthly self-checks, done during a relaxed moment (not immediately after intense activity when the uterus may be contracted), are sufficient. Squat down, insert a clean finger, and feel for the two threads extending from the cervix. If you have been doing this consistently and suddenly cannot feel them, call your clinic.

Strength training and the levator ani

There is no evidence that pelvic floor exercises (Kegels, heavy barbell squats, Olympic lifts) displace an IUD. The device sits above the internal cervical os. Strengthening the pelvic floor, which is a common goal for postpartum athletes, does not create forces at the uterine level that would move the device.

Nutrition considerations for IUD users who train

Iron status matters. Even though the LNG-IUD reduces menstrual blood loss, in the first 3-6 months of use spotting and irregular bleeding can continue. Female athletes already face higher rates of iron deficiency than male athletes. During the adjustment period, monitoring ferritin (not just hemoglobin) is reasonable if you are training heavily. A serum ferritin below 30 mcg/L is associated with impaired aerobic performance in female athletes, per research published in the British Journal of Sports Medicine.

What we do not know: honest gaps in the evidence

The evidence base for LNG-IUD and exercise is thin. No randomized controlled trial has specifically enrolled athletic women to measure serum LNG before and after structured exercise bouts. No study has measured intra-uterine LNG concentrations during or after high-intensity training. The reassurance that exercise does not matter is based on sound pharmacokinetic reasoning (membrane-controlled, local-release mechanism) rather than a dedicated exercise-pharmacology trial.

Women with RED-S (relative energy deficiency in sport) represent a specific gap. Energy availability below 30 kcal/kg of fat-free mass per day alters hypothalamic GnRH pulsatility, estrogen levels, and bone metabolism. Whether profound energy deficiency modifies the endometrial response to LNG or changes the IUD's bleeding pattern beyond what is expected has not been studied. If you are an elite or high-volume recreational athlete with very low body fat and disordered eating history, discussing RED-S specifically with a sports medicine clinician or women's-health dietitian is warranted. The IUD will still work as a contraceptive, but the full hormonal picture may need assessment.